Bionano Genomics BNGO Institutional Ownership

Bionano Genomics, Inc. (NASDAQ:BNGO) has 35 institutional investors that have filed 13F reports for the period ending June 2026.

• These investors collectively held 6.1% of Bionano Genomics's outstanding shares in June 2026, down from 7.9% in March 2026.
• They decreased total shares held in Bionano Genomics by -15.41% from last quarter, and the number of investors in BNGO increased 20.69% annually.
• Of these 35 holders, 20 added to their stakes in Bionano Genomics, 2 trimmed positions, and 13 made no changes.
• Combined, these investors held 709.45K shares in BNGO for June 2026, down by 129.24K shares quarter on quarter, and up 612.01K shares year over year.
• GSA CAPITAL PARTNERS LLP leads ownership in BNGO with 150.28K shares as of June 30, 2026, equal to 1.3% of outstanding shares.
• The most significant purchases of BNGO for the quarter ending June 2026 came from CARRET ASSET MANAGEMENT, LLC (55.0K), JANE STREET GROUP, LLC (35.73K), XTX Topco Ltd (16.3K), VANGUARD CAPITAL MANAGEMENT LLC (14.28K), HRT FINANCIAL LP (11.74K).
• The largest sellers of Bionano Genomics for the quarter ending June 2026 were GSA CAPITAL PARTNERS LLP (203.08K), GEODE CAPITAL MANAGEMENT, LLC (77.54K).
• Per Business Quant, the top 10 investors in BNGO for the quarter ending June 2026 include GSA CAPITAL PARTNERS LLP (150.28K), CARRET ASSET MANAGEMENT, LLC (125.0K), GEODE CAPITAL MANAGEMENT, LLC (89.99K), VANGUARD CAPITAL MANAGEMENT LLC (82.39K), VANGUARD FIDUCIARY TRUST CO (51.58K), RENAISSANCE TECHNOLOGIES LLC (51.1K), JANE STREET GROUP, LLC (35.73K), Prudential Financial Inc (31.6K), Northern Trust Corp (24.56K), XTX Topco Ltd (16.3K).